Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
23.6% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
11
users have liked this narrative
2
users have commented on this narrative
42
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
23.7% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
4.3% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
5
users have liked this narrative
2
users have commented on this narrative
16
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Senzime
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
US And European Guidelines Will Expand Neuromuscular Monitoring Adoption Worldwide
Key Takeaways Adoption driven by regulatory changes and expansion into new patient segments supports scalable, predictable growth and strengthens market position globally. Product innovation and recurring revenue streams improve margins, offsetting economic headwinds and enhancing long-term earnings stability.
View narrative
SEK 12.80
FV
49.7% undervalued
intrinsic discount
81.30%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
1 day ago
author updated this narrative
P3 Health Partners
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
US Healthcare Operational Improvements Will Pave Path To Profitability
Key Takeaways Strategic initiatives in operational efficiencies, contracting, and execution aim to significantly boost EBITDA, net margins, and earnings. Innovative programs and strategic partnerships enhance service offerings and revenue predictability, supporting long-term profitability and growth.
View narrative
US$8.00
FV
15.3% undervalued
intrinsic discount
2.53%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
1 day ago
author updated this narrative
LARK Distilling
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Luxury Whisky Brand Restage Will Open Global Markets
Key Takeaways LARK's strategic focus on luxury branding and international expansion, especially in Asia, is set to boost long-term revenue and brand equity. D2C channel growth and capital discipline aim to enhance market penetration, operational efficiency, and sustainable shareholder value, improving net margins.
View narrative
AU$2.00
FV
61.8% undervalued
intrinsic discount
24.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
1 day ago
author updated this narrative
Neuronetics
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Expanding Mental Healthcare Outreach Will Unlock Future Potential
Key Takeaways Strategic provider programs and operational improvements are enhancing patient conversion, driving higher procedure volumes, and improving operating margins. Expansion into adolescent care and broader market acceptance are creating new revenue streams, supporting sustained multi-year growth and brand differentiation.
View narrative
US$6.50
FV
48.6% undervalued
intrinsic discount
21.45%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
1 day ago
author updated this narrative
EDAP TMS
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
CE Mark And Global Expansion Will Elevate HIFU Adoption
Key Takeaways New approvals and strategic collaborations enhance EDAP TMS's market opportunities, potentially driving future revenue growth and improving margins. Expanded market presence through international and U.S. expansions may lead to increased utilization and revenue from Focal One.
View narrative
US$5.75
FV
76.3% undervalued
intrinsic discount
6.03%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
1 day ago
author updated this narrative
Agenus
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Advanced Immuno-Oncology Therapies Will Reshape Future Cancer Care
Key Takeaways Strong clinical data and regulatory momentum could accelerate product approvals, drive significant market expansion, and improve near-term and long-term earnings potential. Strategic non-dilutive transactions and operational efficiencies bolster financial stability, enabling sustained R&D investment and enhancing margins and profitability prospects.
View narrative
US$11.00
FV
57.9% undervalued
intrinsic discount
7.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
1 day ago
author updated this narrative
Sportsman's Warehouse Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Hunting And Fishing Focus And Omnichannel Retail Will Boost Efficiency
Key Takeaways Focus on core strengths in hunting and fishing, improved inventory, and local strategies are expected to drive revenue growth and enhance margins. Emphasis on omnichannel retail, e-commerce improvements, and personal protection expansion could boost sales, diversify revenue, and enhance customer experiences.
View narrative
US$3.45
FV
21.7% undervalued
intrinsic discount
1.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
1 day ago
author updated this narrative
Calix
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Hybrid Energy And US Water Projects Will Define Future Efficiency
Key Takeaways Advancements in electrification technology could reduce operational costs and improve net margins through lower fossil fuel dependency. Restructuring and reduced headcount aim to enhance profitability, while strong revenue growth and strategic collaborations promise future revenue increases.
View narrative
AU$1.70
FV
71.5% undervalued
intrinsic discount
33.04%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
1 day ago
author updated this narrative
BioLargo
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
PFAS, Battery Tech And Medical Launches Will Shape Markets
Key Takeaways Transformative technologies and strategic partnerships could drive substantial revenue growth and improve net margins by reducing investment risks. Market entry of FDA-compliant medical products and successful retail expansion could enhance revenue and stabilize financial health.
View narrative
US$0.35
FV
49.4% undervalued
intrinsic discount
10.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
1 day ago
author updated this narrative
Value any company in seconds
Popular companies